{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "20188172", "DateCompleted": {"Year": "2010", "Month": "07", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2010", "Month": "02", "Day": "24"}], "Language": ["eng"], "ELocationID": ["10.1016/j.phrs.2010.02.007"], "Journal": {"ISSN": "1096-1186", "JournalIssue": {"Volume": "61", "Issue": "6", "PubDate": {"Year": "2010", "Month": "Jun"}}, "Title": "Pharmacological research", "ISOAbbreviation": "Pharmacol Res"}, "ArticleTitle": "Discovery of cyclooxygenase inhibitors from medicinal plants used to treat inflammation.", "Pagination": {"StartPage": "519", "EndPage": "524", "MedlinePgn": "519-24"}, "Abstract": {"AbstractText": ["Eleven authenticated botanicals used in the traditional Chinese medicine Huo-Luo-Xiao-Ling Dan were screened for ligands to cyclooxygenase (COX) using pulsed ultrafiltration liquid chromatography-mass spectrometry, and a mass spectrometry-based enzyme assay was used to determine the concentration of each of 17 ligands that inhibited COX-1 or COX-2 by 50% (IC(50)). Acetyl-11-keto-beta-boswellic acid, beta-boswellic acid, acetyl-alpha-boswellic acid, acetyl-beta-boswellic acid, and betulinic acid were COX-1 selective inhibitors with IC(50) values of approximately 10 microM. Senkyunolide O and cryptotanshinone were COX-2 selective inhibitors with IC(50) values of 5 microM and 22 microM, respectively. Roburic acid and phenethyl-trans-ferulate inhibited COX-1 and COX-2 equally. COX inhibition and the IC(50) values of most of these natural product ligands have not been reported previously."], "CopyrightInformation": "(c) 2010 Elsevier Ltd. All rights reserved."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, University of Illinois College of Pharmacy, 833 S. Wood Street, Chicago, IL, USA."}], "Identifier": [], "LastName": "Cao", "ForeName": "Hongmei", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yu", "ForeName": "Rui", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Choi", "ForeName": "Yongsoo", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ma", "ForeName": "Zhong-Ze", "Initials": "ZZ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhang", "ForeName": "Hongjie", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Xiang", "ForeName": "Wei", "Initials": "W"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lee", "ForeName": "David Yue-Wei", "Initials": "DY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Berman", "ForeName": "Brian M", "Initials": "BM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Moudgil", "ForeName": "Kamal D", "Initials": "KD"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fong", "ForeName": "Harry H S", "Initials": "HH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "van Breemen", "ForeName": "Richard B", "Initials": "RB"}], "GrantList": [{"GrantID": "P50 AT000155", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}, {"GrantID": "P01 CA48112", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "P50 AT00155", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}, {"GrantID": "P50 AT000155-099004", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}, {"GrantID": "P01 CA048112", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "P01 AT002605", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}, {"GrantID": "S10 RR023785", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "S10 RR023785-01", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "P01 CA048112-170010", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Pharmacol Res", "NlmUniqueID": "8907422", "ISSNLinking": "1043-6618"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclooxygenase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "huo luo xiao ling dan"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Cyclooxygenase 1"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Cyclooxygenase 2"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclooxygenase 1"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclooxygenase 2"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cyclooxygenase Inhibitors"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Humans"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Kvien TK. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics. 2004;22:1\u201312.", "ArticleIdList": ["15157000"]}, {"Citation": "Zhang RX, Fan AY, Zhou AN, Moudgil KD, Ma ZZ, Lee DY, Fong HH, Berman BM, Lao L. Extract of the Chinese herbal formula Huo Luo Xiao Ling Dan inhibited adjuvant arthritis in rats. J Ethnopharmacol. 2009;121:366\u201371.", "ArticleIdList": ["PMC2818782", "19100323"]}, {"Citation": "Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004;343:1\u201319.", "ArticleIdList": ["15188733"]}, {"Citation": "Ho LJ, Lai JH. Chinese herbs as immunomodulators and potential disease-modifying antirheumatic drugs in autoimmune disorders. Curr Drug Metab. 2004;5:181\u201392.", "ArticleIdList": ["15078195"]}, {"Citation": "Lao L, Fan AY, Zhang RX, Zhou A, Ma ZZ, Lee DY, Ren K, Berman B. Anti-hyperalgesic and anti-inflammatory effects of the modified Chinese herbal formula Huo Luo Xiao Ling Dan (HLXL) in rats. Am J Chin Med. 2006;34:833\u201344.", "ArticleIdList": ["17080548"]}, {"Citation": "Chadwick LR, Fong HHS. Quality assurance and standardization in herb-drug interaction evaluation and documentation. In: Lam YWF, Huang S-M, Hall SD, editors. Herbal supplement\u2013drug interactions: scientific and regulatory perspectives. Taylor & Francis; New York: 2006. pp. 191\u2013204."}, {"Citation": "Fong HHS, Pauli GF, Bolton JL, van Breemen RB, Banuvar S, Shulman L, Geller SE, Farnsworth NR. Chapter 2: Evidence-based herbal medicine: challenges in efficacy and safety assessments. In: Leung PC, Fong H, Xue CC, editors. Annals of traditional Chinese medicine \u2013 Vol 2, Current review of Chinese medicine: quality control of herbs and herbal medicine. World Scientific; New Jersey: 2006. pp. 11\u201326."}, {"Citation": "van Breemen RB, Fong HH, Farnsworth NR. The role of quality assurance and standardization in the safety of botanical dietary supplements. Chem Res Toxicol. 2007;20:577\u201382.", "ArticleIdList": ["PMC2570109", "17362032"]}, {"Citation": "van Breemen RB, Huang CR, Nikolic D, Woodbury CP, Zhao YZ, Venton DL. Pulsed ultrafiltration mass spectrometry: a new method for screening combinatorial libraries. Anal Chem. 1997;69:2159\u201364.", "ArticleIdList": ["9183179"]}, {"Citation": "Zhao YZ, van Breemen RB, Nikolic D, Huang CR, Woodbury CP, Schilling A, Venton DL. Screening solution-phase combinatorial libraries using pulsed ultrafiltration/electrospray mass spectrometry. J Med Chem. 1997;40:4006\u201312.", "ArticleIdList": ["9406591"]}, {"Citation": "Nikolic D, van Breemen RB. Screening for inhibitors of dihydrofolate reductase using pulsed ultrafiltration mass spectrometry. Comb Chem High Throughput Screen. 1998;1:47\u201355.", "ArticleIdList": ["10499129"]}, {"Citation": "Nikolic D, Habibi-Goudarzi S, Corley DG, Gafner S, Pezzuto JM, van Breemen RB. Evaluation of cyclooxygenase-2 inhibitors using pulsed ultrafiltration-mass spectrometry. Anal Chem. 2000;72:3853\u201359.", "ArticleIdList": ["10959973"]}, {"Citation": "Gu C, Nikolic D, Lai J, Xu X, van Breemen RB. Assays of ligand-human serum albumin binding using pulsed ultrafiltration and liquid chromatography-mass spectrometry. Comb Chem High Throughput Screen. 1999;2:353\u20139.", "ArticleIdList": ["10644860"]}, {"Citation": "Sun Y, Gu C, Liu X, Liang W, Yao P, Bolton JL, van Breemen RB. Ultrafiltration tandem mass spectrometry of estrogens for characterization of structure and affinity for human estrogen receptors. J Am Soc Mass Spectrom. 2005;16:271\u20139.", "ArticleIdList": ["PMC1780173", "15694777"]}, {"Citation": "Liu D, Guo J, Luo Y, Broderick DJ, Schimerlik MI, Pezzuto JM, van Breemen RB. Screening for ligands of human retinoid X receptor-\u03b1using ultrafiltration mass spectrometry. Anal Chem. 2007;79:9398\u2013402.", "ArticleIdList": ["PMC2570161", "17997524"]}, {"Citation": "Noreen Y, Ringbom T, Perera P, Danielson H, Bohlin L. Development of a radiochemical cyclooxygenase-1 and -2 in vitro assay for identification of natural products as inhibitors of prostaglandin biosynthesis. J Nat Prod. 1998;61:2\u20137.", "ArticleIdList": ["9461646"]}, {"Citation": "Belsner K, Buchele B, Werz U, Syrovets T, Simmet T. Structural analysis of pentacyclic triterpenes from the gum resin of Boswellia serrata by NMR spectroscopy. Magn Reson Chem. 2003;41:115\u201322."}, {"Citation": "Culioli G, Mathe C, Archier P, Vieillescazes C. A lupane triterpene from frankincense (Boswellia sp., Burseraceae). Phytochemistry. 2003;62:537\u201341.", "ArticleIdList": ["12560022"]}, {"Citation": "Peng C, Bodenhausen G, Qiu S, Fong H, Farnsworth N, Yuan S, Zheng C. Computer-assisted structure elucidation: application of CISOC-SES to the resonance assignment and structure generation of betulinic acid. Magn Reson Chem. 1998;36:267\u201378."}, {"Citation": "Naito T, Katsuhara T, Niitsu K, Ikeya Y, Okada M, Mitsuhashi H. Phthalide dimers from Ligusticum chuangxiong Hort. Heterocycles. 1991;32:2433\u201342."}, {"Citation": "Chen QL, Shi ZY, Tu GZ, Sun WJ. [Studies on the chemical constituents in root of Gentiana macrophylla from Shaanxi]. Zhongguo Zhong Yao Za Zhi. 2005;30:1519\u201322.", "ArticleIdList": ["16335823"]}, {"Citation": "Zdero C, Jakupovic J, Bohlmann F. Diterpenes and other constituents from Pteronia Species. Phytochemistry. 1990;29:1231\u201345."}, {"Citation": "Sairafianpour M, Christensen J, Staerk D, Budnik BA, Kharazmi A, Bagherzadeh K, Jaroszewski JW. Leishmanicidal, antiplasmodial, and cytotoxic activity of novel diterpenoid 1,2-quinones from Perovskia abrotanoides: new source of tanshinones. J Nat Prod. 2001;64:1398\u20131403.", "ArticleIdList": ["11720520"]}, {"Citation": "Cuendet M, Mesecar AD, DeWitt DL, Pezzuto JM. An ELISA method to measure inhibition of the COX enzymes. Nat Protoc. 2006;1:1915\u201321.", "ArticleIdList": ["17487176"]}, {"Citation": "Cao H, Xiao L, Park G, Wang X, Azim AC, Christman JW, van Breemen RB. An improved LC-MS/MS method for the quantification of prostaglandins E2 and D2 production in biological fluids. Anal Biochem. 2008;372:41\u201351.", "ArticleIdList": ["PMC2276632", "17976507"]}, {"Citation": "Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, Graneto MJ, Lee LF, Malecha JW, Miyashiro JM, Rogers RS, Rogier DJ, Yu SS, Anderson GD, Burton EG, Cogburn JN, Gregory SA, Koboldt CM, Perkins WE, Seibert K, Veenhuizen AW, Zhang YY, Isakson PC. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, Celecoxib). J Med Chem. 1997;40:1347\u201365.", "ArticleIdList": ["9135032"]}, {"Citation": "Marnett LJ, Kalgutkar AS. Cyclooxygenase 2 inhibitors: discovery, selectivity and the future. Trends Pharmacol Sci. 1999;20:465\u20139.", "ArticleIdList": ["10542447"]}, {"Citation": "Gierse JK, Koboldt CM, Walker MC, Seibert K, Isakson PC. Kinetic basis for selective inhibition of cyclo-oxygenases. Biochem J. 1999;339:607\u201314.", "ArticleIdList": ["PMC1220196", "10215599"]}, {"Citation": "Kang SS, Cuendet M, Endringer DC, Croy VL, Pezzuto JM, Lipton MA. Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB. Bioorg Med Chem. 2009;17:1044\u201354.", "ArticleIdList": ["18487053"]}, {"Citation": "Siemoneit U, Hofmann B, Kather N, Lamkemeyer T, Madlung J, Franke L, Schneider G, Jauch J, Poeckel D, Werz O. Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids. Biochem Pharmacol. 2008;75:503\u201313.", "ArticleIdList": ["17945191"]}, {"Citation": "Yogeeswari P, Sriram D. Betulinic acid and its derivatives: a review on their biological properties. Curr Med Chem. 2005;12:657\u201366.", "ArticleIdList": ["15790304"]}, {"Citation": "Zschocke S, Lehner M, Bauer R. 5-Lipoxygenase and cyclooxygenase inhibitory active constituents from Qianghuo (Notopterygium incisum). Planta Med. 1997;63:203\u20136.", "ArticleIdList": ["9265192"]}, {"Citation": "Jin DZ, Yin LL, Ji XQ, Zhu XZ. Cryptotanshinone inhibits cyclooxygenase-2 enzyme activity but not its expression. Eur J Pharmacol. 2006;549:166\u201372.", "ArticleIdList": ["16989810"]}]}], "History": [{"Year": "2010", "Month": "2", "Day": "11"}, {"Year": "2010", "Month": "2", "Day": "16"}, {"Year": "2010", "Month": "2", "Day": "17"}, {"Year": "2010", "Month": "3", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "3", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "7", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "6", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["20188172", "NIHMS189608", "PMC2860736", "10.1016/j.phrs.2010.02.007", "S1043-6618(10)00059-9"]}}], "PubmedBookArticle": []}